Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008

類似資料

• Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience
  著者:: Ganzel, Chezi, 等
  出版事項: (2018)
• Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
  著者:: Fernandez, Hugo F., 等
  出版事項: (2019)
• The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ ECOG-ACRIN Study (S0106 and E1900)
  著者:: Medeiros, Bruno C., 等
  出版事項: (2019)
• Younger adults with acute myeloid leukemia in remission for ≥3 years have a high likelihood of cure: the ECOG experience in over 1200 patients
  著者:: Watts, Justin M., 等
  出版事項: (2014)
• At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial
  著者:: Ganzel, Chezi, 等
  出版事項: (2020)